Brinker ( EAT) estimates, target were increased at Keybanc. Estimates were raised through 2015. Checks show better profitability trends, Keybanc said. Buy rating and new $45 price target. Facebook ( FB) estimates, price target were reduced at Oppenheimer. Shares are now seen reaching $32. Estimates also cut, given a lower outlook for mobile ad monetization, Oppenheimer said. Outperform rating. Family Dollar ( FDO) estimates were cut at Jefferies. Estimates were reduced through 2014. Company is facing margin pressure, Jefferies said. Hold rating and $57 price target. Gap ( GPS) price target was boosted at Jefferies to $56. Athleta continues to grow in value, Jefferies said. Buy rating. JCPenney ( JCP) estimates were reduced at UBS. Earnings estimates through 2014 were cut after the company announced CEO Ron Johnson's departure, said UBS. The company has returned to heavier couponing in a weak sales environment. Price target remains $10. Lazard ( LAZ) estimates, price target were cut at Credit Suisse. Shares are now seen reaching $39. Estimates also reduced, given fewer deal closings, Credit Suisse said. Outperform rating. Las Vegas Sands ( LVS) estimates were increased at Wells Fargo. Estimates were boosted through 2014. Macau continues to grow ahead of expectations, Wells Fargo said. Outperform rating. Rite Aid ( RAD) price target and estimates were increased at UBS. Earnings estimates through 2014 were increased ahead of its earnings release on Thursday, said UBS. Debt refinancing will offset other EPS headwinds, UBS said. Price target is now $1.80. UnitedHealth ( UNH) target raised at Credit Suisse to $71. PBM business is not being appreciated by investors, Credit Suisse said. Outperform rating. Xcel Energy ( XEL) numbers were raised at Jefferies. Shares are now seen reaching $30.50. Estimates were also increased, given higher expected energy rates, Jefferies said. Hold rating. Follow TheStreet on Twitter and become a fan on Facebook.